Study of a Live Attenuated Japanese Encephalitis Chimeric Virus Vaccine (IMOJEV™) Compared to CD.JEVAX™ in Toddlers

Clinical trial NCT01396512 · COMPLETED

Trial details

NCT number: NCT01396512
Sponsor: Sanofi Pasteur, a Sanofi Company
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Japanese Encephalitis Japanese Encephalitis Virus Disease

Start date: 2011-07-01
Primary completion: 2013-03-01
Enrollment: 274

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.